As of Dec 14
| -1.08 / -1.27%|
The 13 analysts offering 12-month price forecasts for ResMed Inc have a median target of 78.25, with a high estimate of 90.00 and a low estimate of 55.00. The median estimate represents a -6.76% decrease from the last price of 83.93.
The current consensus among 17 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.